http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4419359-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D461-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D461-00
filingDate 1982-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1983-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f03c0f9f0cc081957151f446a3dcfa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47ce47223b27bfb76b237dc27cb6e14c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35fb06d6ae3b13accfe0e9d49315152f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cb3729b65365bcb045a0eea5415c2ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_203fa31a9996a44bdbf66f14f91d8e91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c201fd4a2314a529451b07a5ee3826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fc56941e0c27c92b93d9f37846e89bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fab76f7a853958ab835bb59072ae519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61294fc398ad81d5a43edab989896d7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0fd66d0b91f1497968cf35f5c77c271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb97844af4aa232152f51e0d989a200f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_440d8c58798192cc7e1efa9541f72fdc
publicationDate 1983-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4419359-A
titleOfInvention Nitro-substituted polycyclic derivatives useful in the treatment of psoriasis
abstract The present invention relates to the compounds of the Formulae 1a and 1b and pharmaceutically acceptable acid addition salts thereof. The new 9-nitro-apovincaminol-3',4',5'-trimethoxybenzoate of the Formula 1a <IMAGE> and the 11-nitro-apovincaminol-3',4',5'-trimethoxy-benzoate of the Formula 1b <IMAGE> and pharmaceutically acceptable acid addition salts thereof can be prepared by nitrating the apovincaminol-3',4',5'-trimethoxy-benzoate of the Formula 11, <IMAGE> if desired separating the mixture of the compounds of the Formulae 1a and 1b thus obtained into its components, if desired converting a compound of the Formula 1a or 1b thus obtained into pharmaceutically acceptable acid addition salts thereof. The new compounds of the present invention can be used in therapy in the treatment of psoriasis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4746665-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4680397-A
priorityDate 1981-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4328231-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4108996-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4065458-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2342980-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66588621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73950587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127569279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87058044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79075
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226572518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129246272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226404049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226404050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398407

Total number of triples: 65.